Semler Scientific (SMLR) has disclosed a new risk, in the Trade Secrets category.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Semler Scientific faces a significant business risk due to its potential reliance on third-party intellectual property for the development and commercialization of its vascular testing products. If a third party holds essential patent rights, Semler may need to secure licenses to use this technology. However, these licenses may not be available or could be offered on terms that are not commercially viable, posing a substantial threat to the company’s business operations and financial health.
Overall, Wall Street has a Strong Buy consensus rating on SMLR stock based on 3 Buys.
To learn more about Semler Scientific’s risk factors, click here.